机器人腹膜后淋巴结清扫术的适应症、技术进展及早期疗效
Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.
作者信息
Werntz Ryan P, Pearce Shane M, Eggener Scott E
机构信息
Section of Urology, Department of Surgery, The University of Chicago Medicine.
Institute of Urology, University of Southern California, Los Angeles, California, USA.
出版信息
Curr Opin Urol. 2018 Sep;28(5):461-468. doi: 10.1097/MOU.0000000000000530.
PURPOSE OF REVIEW
Examine and discuss indications, technique, and outcomes for robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer.
RECENT FINDINGS
Open RPLND has been the longstanding standard of care for both primary and post chemotherapy RPLND. Recently, robotic RPLND has been an attractive option with the intent of reducing the morbidity associated with open surgery while providing identical oncologic efficacy. Naysayers of robotic RPLND suggest it is often inappropriately used as a staging procedure and consequently can compromise oncologic efficacy.
SUMMARY
Robotic RPLND is being evaluated as a therapeutic equivalent to open RPLND. On the basis of limited published data with modest follow-up from experienced centers, robotic RPLND appears to provide effective staging and therapeutic data mirroring that of open surgery.
综述目的
探讨并讨论机器人腹膜后淋巴结清扫术（RPLND）治疗睾丸癌的适应证、技术及疗效。
最新发现
开放性RPLND一直是原发性及化疗后RPLND的长期标准治疗方法。近来，机器人RPLND成为一个有吸引力的选择，旨在降低与开放手术相关的发病率，同时提供相同的肿瘤学疗效。机器人RPLND的反对者认为，它常被不恰当地用作分期手术，因此可能会影响肿瘤学疗效。
总结
机器人RPLND正在被评估为与开放性RPLND等效的治疗方法。基于经验丰富的中心有限的已发表数据及适度的随访，机器人RPLND似乎能提供与开放手术相似的有效分期及治疗数据。
Zotero 插件